Drug Type T-lymphocyte cell therapy |
Synonyms- |
Target- |
Mechanism T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Caliciviridae Infections | Phase 1 | US | 26 Oct 2020 | |
Graft vs Host Disease | Phase 1 | US | 26 Oct 2020 | |
Hematopoietic stem cell transplantation | Phase 1 | US | 26 Oct 2020 | |
Pelvic Inflammatory Disease | Phase 1 | US | 26 Oct 2020 | |
Primary Immunodeficiency Diseases | Phase 1 | US | 26 Oct 2020 |